Viamet raises $60M from private funds instead of going public

Instead of entering the publicly traded realm, Durham's Viamet Pharmaceuticals was able to raise $60 million in private money, enough to give the company a two-year cash runway, according to company executives...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.